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Abstract
Objectives Computed tomography (CT) can perform compre-
hensive cardiac imaging. We compared CT coronary angiog-
raphy (CTCA) and CT myocardial perfusion (CTP) with 15O-
water positron emission tomography (PET) and invasive cor-
onary angiography (ICA) with fractional flow reserve (FFR).
Methods 51 patients (63 (61–65) years, 80 % male) with
known/suspected coronary artery disease (CAD) underwent
320-multidetector CTCA followed by Bsnapshot^ adenosine
stress CTP. Of these 22 underwent PET and 47 ICA/FFR.
Obstructive CAD was defined as CTCA stenosis >50 % and
CTP hypoperfusion, ICA stenosis >70 % or FFR <0.80.
Results PET hyperaemic myocardial blood flow (MBF) was
lower in obstructive than non-obstructive territories defined by
ICA/FFR (1.76 (1.32–2.20) vs 3.11 (2.44–3.79) mL/(g/min),
P < 0.001) and CTCA/CTP (1.76 (1.32–2.20) vs 3.12 (2.44–
3.79) mL/(g/min), P < 0.001). Baseline and hyperaemic CT at-
tenuation density was lower in obstructive than non-obstructive
territories (73 (71–76) vs 86 (84–88) HU, P < 0.001 and 101
(96–106) vs 111 (107–114) HU, P 0.001). PET hyperaemic
MBF corrected for rate pressure product correlated with CT
attenuation density (r = 0.579, P < 0.001). There was excellent
per-patient sensitivity (96 %), specificity (85 %), negative pre-
dictive value (90 %) and positive predictive value (94 %) for
CTCA/CTP vs ICA/FFR.
Conclusion CT myocardial attenuation density correlates
with 15O-water PET MBF. CTCA and CTP can accurately
identify obstructive CAD.
Key Points
• CT myocardial perfusion can aid the assessment of
suspected coronary artery disease.
• CTattenuation density from Bsnapshot^ imaging is a marker
of myocardial perfusion.
• CT myocardial attenuation density correlates with 15O-wa-
ter PET myocardial blood flow.
• CT attenuation density is lower in obstructive territories
defined by invasive angiography.
• Diagnostic accuracy of CTCA+CTP is comparable to inva-
sive angiography + fractional flow reserve.
Keywords Imaging . Perfusion . Ischaemia . Angiography .
Angina
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Introduction
Computed tomography coronary angiography (CTCA) can be
performed at low radiation dose and has an excellent negative
predictive value in the assessment of coronary artery disease
(CAD) [1, 2]. However, areas of high density, such as calcifi-
cation or stents, can reduce its accuracy. The concomitant
assessment of myocardial perfusion could address this issue
by providing additive functional information. Computed to-
mography myocardial perfusion (CTP) has the potential to
improve the diagnostic accuracy of CTCA and can be per-
formed during the same examination [3].
The selection of patients for coronary revascularization is
based on the functional significance of stenoses. This is best
characterised by fractional flow reserve (FFR) which is the
current gold standard method of defining obstructive CAD
and can lead to improved clinical outcomes when used to
guide therapy [4]. However, FFR assessment requires inva-
sive coronary angiography (ICA) and is a derived ratio of
pressure rather than a direct measurement of blood flow.
Other methods, such as magnetic resonance imaging (MRI)
or single photon emission computed tomography (SPECT)
can non-invasively assess myocardial perfusion. However,
all investigations may be limited by spatial resolution, imag-
ing artefacts, long imaging times and false negatives due to
balanced ischaemia in three-vessel disease [5, 6].
Positron emission tomography (PET) using oxygen-15-
labeled water (15O-water) is the gold standard for the assess-
ment of myocardial perfusion as it is a freely diffusible meta-
bolically inert tracer, with a high extraction fraction that is
independent of flow rate [7]. This tracer enables quantitative
assessment of absolute myocardial blood flow, rather than
relative myocardial blood flow identified by visual assessment
in other techniques. 15O-Water PET myocardial blood flow
measurements have been validated with radiolabelled micro-
spheres in animal models [8, 9] and compared with ICA, ICA/
FFR, SPECT, MRI and CTCA in human studies [10–14]. It
has good intraobserver and interobserver variability as well as
a low inter-scan variability for absolute myocardial blood flow
[15, 16].
The diagnostic accuracy of CTmyocardial perfusion imag-
ing has been established in multi-centre studies as compared
to SPECT [17] and SPECT+ICA [3]. In addition, there have
been a number of single-centre studies comparing Bsnapshot^
or Bdynamic^ CT myocardial perfusion imaging to a variety
of gold standard assessments, including FFR [18, 19]. The
acceptability of this non-invasive test to patients is also good
[20]. However, snapshot CT myocardial perfusion imaging
has not previously been assessed as compared to the physio-
logical gold standard of 15O-water PET myocardial blood
flow. Furthermore, semi-quantitative assessment of CT myo-
cardial perfusion imaging with measurements of attenuation
density has not been assessed as compared to either clinical
(FFR) or physiological (15O-water PET myocardial blood
flow) gold standards.
This study assessed snapshot CT myocardial perfusion im-
aging (also known as single-shot, static and single-phase myo-
cardial perfusion imaging), which obtains a small number of
images at maximal contrast enhancement. In order to thor-
oughly assess this technique we compared it to both the phys-
iological gold standard of absolute myocardial blood flow
(measured with 15O-water PET) and the clinical gold standard
measure of coronary stenosis severity (FFR during ICA).
Methods
The study was conducted in accordance with the Declaration
of Helsinki, with local research ethics committee approval and
written informed consent of all participants.
Study population
Participants had known or suspected CAD and were due to
undergo ICA for clinical indications. Exclusion criteria were
renal failure (serum creatinine greater than 2.26 mg/dL or
estimated glomerular filtration rate less than 30 mL/min), al-
lergy to iodinated contrast, pregnancy or contraindication to
adenosine. All patients who met the inclusion and exclusion
criteria were invited to participate, and of these 19 % agreed.
Cardiovascular risk was assessed using the Framingham 10-
year cardiovascular risk score.
Computed tomography
Participants underwent rest and adenosine stress computed
tomography (CT) using a 320-multidetector scanner
(Aquilion ONE, ToshibaMedical Systems, Japan). They were
asked to refrain from caffeine for 12 h. Participants with a
heart rate greater than 65/min were administered intravenous
metoprolol (maximum 25 mg). Sublingual glyceryl trinitrate
(300 μg tablet) was administered prior to, and removed im-
mediately after, rest imaging.
After acquisition of scout images, patients underwent non-
contrast wide volume CT using tube voltage 120 kV, tube
current based on body mass index (BMI) and scan range from
2 cm below the carina to the base of the heart using volume
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sizes of 160, 140, 128, 120, 100 or 80 mm. Participants then
underwent resting prospective wide volume CTCA. The de-
tector coverage was based on non-contrast imaging and the
acquisition window was based on heart rate (70–80 % of the
RR interval for heart rates less than 60/min, 30–80 % of the
RR interval for heart rates greater than 60/min or irregular
heart rates). Tube voltage and current were based on BMI or
scout image attenuation. A triphasic injection of iodinated
intravenous contrast (iomeprol, 400 mg iodine/mL; Iomeron
400, Bracco, UK) was administered based on BMI (less than
30 kg/m2, 50 mL; 30–39 kg/m2, 60 mL; at least 40 kg/m2,
70 mL). Bolus triggering started the scan when descending
aorta enhancement reached 300 Hounsfield units (HU). Stress
imaging was performed 10 min after rest imaging and after
4 min of adenosine (140μg/(kg/min)). The same tube voltage,
tube current and contrast were used as for rest imaging.
However, scan range was reduced to cover only the left ven-
tricle, and tube current modulation obtained data over a single
heartbeat. A further low dose CT (100 kV, targeted 75 %
acquisition) was performed at 3 to 4 min to assess myocardial
late enhancement.
Calcium scoring images were reconstructed with filtered
back projection (QuantumDenoising Software, QDS+; kernel
FC02), and CTCA and CTP images were reconstructed with
iterative reconstruction (Adaptive Iterative Dose Reduction
3D, Toshiba Medical Systems, Japan; FC05 or FC03 kernels
[21] respectively). From the rest CTCA acquisition, the scan-
ner console software identified the Bbest phase^ and recon-
structed this phase and those 10 ms either side. Additional
reconstructions at any point in the rest acquisition could be
produced as required. For the stress CTCA, images were re-
constructed every 5 % of the acquisition which covered the
entire RR interval of a single heartbeat. Additional reconstruc-
tions at any point in the stress acquisition could be produced as
required.
Oxygen-15-labelled water positron emission tomography
Rest and stress 15O-water PET-CT was preformed using a
hybrid scanner (128-multidetector Biograph mCT, Siemens
Medical Systems, Germany). Attenuation correction CT was
performed before rest or before rest and stress imaging. An
on-site cyclotron (PETtrace 8, GE Healthcare, UK) produced
15O, and a radiowater generator (Hydex Oy, Finland) pro-
duced the 15O-water bolus. Rest imaging was performed using
a target of 500 MBq 15O-water (15 s bolus, 2-min saline
flush). Dynamic acquisition was performed over 5 min
(14 × 5, 3 × 10, 3 × 20 and 4 × 30 s). After suitable decay (ap-
proximately 10 min), stress imaging was performed with a
further 500 MBq 15O-water. Dynamic acquisition was per-
formed during adenosine infusion. Dynamic emission images
were reconstructed using the UltraHD algorithm (Siemens
Medical Systems, Germany) (zoom 2, matrix 128 × 128,
voxels 3.18 × 3.18 × 3 mm).
Invasive coronary angiography and fractional flow
reserve
ICAwas performed via radial artery as per standard practice.
FFR was assessed for major epicardial vessels with stenosis
greater than 50%, where technically possible. FFR is the ratio
between distal coronary pressure and aortic pressure at maxi-
mal hyperaemia [4]. Pharmacological stress was induced
using adenosine (140 μg/(kg/min)). Obstructive CAD was
defined as luminal stenosis of at least 70 % on ICA or FFR
less than 0.80.
Image analysis
Assessment of imaging was blinded to results of other modal-
ities. CT was analysed using a post-processing workstation
(Vitrea fX, Vital Images, USA). Two trained observers
(MCW, DEN) assessed images separately, and differences
were agreed by consensus. The single phase with the fewest
artefacts was used to assess CT rest and stress imaging. CTP
was assessed as per standard guidelines with adjustment of
viewing parameters as required [22]. Visual analysis of
CTCA was based on the 19-segment model [1] and CTP on
the 17-segment model [23]. Segmental data were consolidated
into three territories for per vessel perfusion analysis [23].
Obstructive CAD was defined as stenosis greater than 50 %
with corresponding hypoperfusion on CTP.
Semi-quantitative assessment of CTP images was per-
formed by assessing CTmyocardial attenuation density at rest
and during maximal hyperaemia. CT images were assessed in
the short axis, and the apex was excluded. Automatically ap-
plied myocardial contours were edited manually as required.
Attenuation density was measured in each myocardial seg-
ment for endocardium, mid-wall, epicardium and full thick-
ness. Transmyocardial perfusion ratio was calculated as the
ratio of segmental subendocardial attenuation divided by
mean subepicardial attenuation of the short-axis slice [24].
PET was analysed using dedicated software (Carimas 2.4,
Finland) using a single tissue compartment model with cor-
rection for perfusable tissue fraction and spillover [15].
Images were reoriented into short-axis and myocardial con-
tours defined on digital subtraction images automatically, with
manual adjustment. Myocardial blood flow was analysed for
the whole left ventricle and segmental data was consolidated
into three territories for per-vessel analysis [23]. Coronary
vasodilator reserve was defined as the ratio of peak
hyperaemic to resting myocardial blood flow [25]. Total cor-
onary resistance was calculated as mean arterial pressure di-
vided by myocardial blood flow at baseline and hyperaemia
[25]. Myocardial blood flow and CT attenuation density were
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corrected for rate pressure product, calculated from heart rate
and blood pressure during imaging.
Statistical analysis
Statistical analysis was performed using SPSS (version 18 for
Mac, IBM). Normally distributed quantitative variables are
presented with mean and 95 % confidence interval. Non-
normally distributed data are presented with median and inter-
quartile range. Statistical significance was assessed using
analysis of variance, Student t or Mann–Whitney U tests as
appropriate. Sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and diagnostic accu-
racy were calculated on a per-vessel and per-patient basis.
Receiver operator characteristic curves were constructed to
assess diagnostic accuracy. Correlations were assessed using
Pearson’s correlations. Inter- and intraobserver variability was
assessed using kappa statistics. A statistically significant dif-
ference was defined as a two-sided P value less than 0.05.
Results
Demographics
CTwas performed in 51 patients (Table 1). ICAwas planned
for all patients but only completed in 47 because of either
patient or clinician preference. PET was performed in 22 pa-
tients who agreed to additional imaging and had not under-
gone revascularization in the intervening time period. All im-
aging was therefore performed prior to any revascularization
procedure.
According to the Framingham 10-year cardiovascular risk
score, 23 (45 %) were high risk, 20 (39 %) intermediate risk
and 8 (16 %) low risk. Thirteen patients had previously expe-
rienced an acute coronary syndrome. Mean coronary artery
calcium score was 870 (580, 1161) Agatston units. ICA/FFR
identified obstructive CAD in 27/47 (57 %) patients and 51/
141 (36 %) of vessels. Participants who underwent PET had
similar demographic details and risk factors compared to the
other participants (Supplementary Table i).
Radiation
Mean dose length product (DLP) for CTwas 641.44 (558.50–
724.24) mGy cm. Using the 0.014 mSv/(mGy cm) conversion
factor, we calculated the dose of rest CT as 2.73 mSv, stress
CT 3.71 mSv and total CT protocol 8.98 mSv. Mean admin-
istered activity of 15O-water was 474 (461–488) MBq for rest
and 465 (448–482) MBq for stress imaging. Mean DLP of
attenuation correction CT was 73 mGy cm. According to the
conversion factors of 0.014 mSv/(mGy cm) and 1.1 μSv/MBq
[26], this equates to a total effective dose of 2.05mSv for PET.
Assessment of myocardial perfusion
15O-Water PET demonstrated that the mean myocardial blood
flow and myocardial blood flow corrected for rate pressure
product for all segments was higher during hyperaemia
(2.52 (2.40–2.64) and 2.65 (2.53–2.77) mL/(g/min) respec-
tively) compared to baseline (0.80 (0.76–0.81) and 0.82
(0.79–0.85) mL/(g/min) respectively; P < 0.001 for both).
There were no differences in baseline 15O-water PET myo-
cardial blood flow between obstructive and non-obstructive
lesions as determined by ICA/FFR (P = 0.74, Table 2,
Fig. 1). However, during hyperaemia, 15O-water PETmyocar-
dial blood flow was lower for obstructive lesions defined by
ICA/FFR on both per-patient and per-vessel assessment
(Table 2, Fig. 1).
There were no differences in baseline 15O-water PET myo-
cardial blood flow in territories supplied by arteries with ob-
structive or non-obstructive lesions as defined by CTCA/CTP
on per-patient or per-vessel analysis (Table 2, Fig. 1).
However, on per-segment analysis, baseline 15O-water PET
myocardial blood flow was lower in territories supplied by
coronary arteries with obstructive lesions (0.65 versus
0.79 mL/(g/min), P < 0.001). Hyperaemic 15O-water PET
myocardial blood flow was lower in territories supplied by
arteries with obstructive lesions defined by CTCA/CTP on
per-patient, per-vessel and per-segment analysis (Table 2,
Table 1 Demographics
N 51
Age (years) 63 (61, 65)
Male/female 41/10 (80/20 %)
Weight (kg) 85.0 (80.0, 90.0)
BMI (kg/m2) 28.6 (27.3, 29.9)
Hypertension 36 (71)
Hypercholesterolaemia 48 (94)
Diabetes mellitus 5 (10)
Cerebrovascular disease 4 (8)
Peripheral vascular disease 2 (4)
Current smoker 9 (18)
Ex-smoker (>1 month) 23 (45)
Family history 24 (47)
Previous acute coronary syndrome 13 (25)
Previous revascularisation 13 (25)
Stent 12 (24)
Coronary artery bypass graft 1 (2)
Invasive coronary angiography
Normal 18 (38)
One-vessel disease 14 (30)
Two-vessel disease 8 (17)
Three-vessel disease 7 (15)
Mean (95 % confidence interval) or number (%)
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Fig. 1). In addition, vessel territories defined as normal by
CTCA/CTP had a higher baseline and hyperaemic 15O-water
PET myocardial blood flow than those with non-obstructive
or obstructive lesions, but this difference was not statistically
significant (Fig. 2).
For per-vessel assessment, the optimal cut-off for 15O-wa-
ter PET myocardial blood flow for assessing the presence of
obstructive stenosis as defined by either ICA/FFR or
CTCA/CTP was 0.52 mL/(g/min) at baseline and 0.78 mL/
(g/min) during hyperaemia (Table 3, Supplementary Table ii).
The area under the curve was higher for hyperaemic than
baseline myocardial blood flow.
Mean CT myocardial attenuation density for all segments
was 85 (83–87) HU at baseline and 111 (107–114) HU during
hyperaemia (P < 0.01). The CT transmyocardial perfusion ra-
tio (TPR) was higher at baseline than hyperaemia (1.68 (1.61–
1.76) versus 1.17 (1.13–1.21), P < 0.001).
CT myocardial attenuation density was lower in territories
supplied by arteries with obstructive as compared to non-
obstructive lesions as defined by ICA/FFR (Table 4). 15O-
Water PET myocardial blood flow correlated with CT myo-
cardial attenuation density (Table 5). The correlation was
greater for the endocardium and when corrected for rate pres-
sure product or left ventricular enhancement (Table 5). 15O-
Water PET myocardial blood flow corrected for rate pressure
product correlated weakly with CT myocardial attenuation
density at rest (r = 0.19, P < 0.001) but correlated well during
hyperaemia (r = 0.579, P < 0.001, Fig. 1). CT transmyocardial
perfusion ratio correlated only weakly with 15O-water PET
myocardial blood flow. However, 15O-water PET defined cor-
onary vasodilator reserve and total coronary resistance corre-
lated more strongly with CT myocardial attenuation density.
Diagnostic accuracy of perfusion imaging
When compared to ICA/FFR, the sensitivity, specificity, PPV
and NPVof CTCA/CTP were 96, 85, 90 and 94 % on a per-
patient basis and 88, 83, 75 and 93 % on a per-vessel basis
(Supplementary Table iii). Inter- and intraobserver variabil-
ities for CT were good (kappa value 0.772, P < 0.001 and
0.721, P < 0.001) and for PET were excellent (kappa value
0.817, P < 0.001 and 0.942, P < 0.001). Figure 3 shows exam-
ple images. Late enhancement was identified on one CT in a
patient with a previous myocardial infarction, and this was
confirmed on subsequent MRI. This shows that the majority
of perfusion defects identified represent reversible ischaemia
rather than infarction.
Discussion
We have assessed combined CT coronary angiography and
snapshot CT myocardial perfusion imaging and have under-
taken simultaneous comparisons with the gold standard mea-
sure of absolute myocardial blood flow (15O-water PET) and
the gold standard measure of coronary stenosis severity (FFR
during invasive coronary angiography). We have demonstrat-
ed for the first time that CT attenuation density correlates with
15O-water PET myocardial blood flow. In addition, CT perfu-
sion identified clinically significant CAD as defined by FFR
with excellent diagnostic accuracy. Thus we provide physio-
logical and clinical evidence to support the use of CT myo-
cardial perfusion imaging.
CTCA is an established technique for the non-invasive
assessment of CAD. However, CTCA alone fails to identify
a significant proportion of functionally significant lesions
compared with ICA/FFR [27]. This is where perfusion imag-
ing has an important discriminatory role and is additive to
CTCA [28]. CORE-320 showed that the CTP and CTCA
has a sensitivity, specificity, PPVand NPV for detecting great-
er than 50 % ICA stenosis with SPECT perfusion defects of
80, 74, 65 and 86 % on a per-patient basis [3]. However,
although SPECT is widely used as the first-line perfusion
imaging technique by many clinicians, it has limitations [29,
30]. Comparisons with SPECT may under-represent the true
value of CTP. We therefore used ICA and FFR as the gold
standard clinical reference comparator and confirmed the di-
agnostic accuracy of CTCA/CTP.
Our study supports the clinical use of CTP in the investiga-
tion of patients with suspected CAD. CTP can be used as an
optional Badd-on^ investigation immediately after CTCAwhen
heavily calcified vessels are identified or if the functional se-
verity of stenosis is uncertain. Alternatively, it can be prospec-
tively planned for patients with CAD being considered for
coronary revascularisation. In addition to identifyingmajor epi-
cardial CAD, CTP can also identify microvascular dysfunction.
Table 2 15O-Water PET myocardial blood flow (mL/(g/min)) for
obstructive and non-obstructive regions as defined by ICA/FFR and
CTCA/CTP
Non-obstructive Obstructive P
ICA/FFR
Per patient Rest 0.88 (0.74, 1.03) 0.63 (0.35, 0.89) 0.074
Stress 3.11 (2.44, 3.79) 1.76 (1.32, 2.20) 0.001
Per vessel Rest 0.84 (0.77, 0.91) 0.78 (0.69, 0.88) 0.3
Stress 2.92 (2.61, 3.23) 1.60 (1.28, 1.91) <0.001
CTCA/CTP
Per patient Rest 0.88 (0.74, 1.03) 0.63 (0.35, 0.90) 0.74
Stress 3.12 (2.44, 3.79) 1.76 (1.32, 2.20) 0.001
Per vessel Rest 0.86 (0.79, 0.94) 0.75 (0.67, 0.84) 0.45
Stress 3.04 (2.70, 3.39) 1.78 (1.51, 2.05) <0.001
Per segment Rest 0.79 (0.76, 0.82) 0.65 (0.61, 0.70) <0.001
Stress 2.77 (2.63, 2.91) 2.09 (1.93, 2.24) <0.001
Mean (95 % confidence interval)
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In our study, some of the false positives were due to the pres-
ence of microvascular dysfunction, highlighted as Bslow flow^
during ICA with a normal FFR. FFR is primarily focused on
identifying a pressure gradient across a functional stenosis but
cannot assess microvascular resistance or flow directly [31].
Other reasons for false positive results may include motion
artefact or beam-hardening artefact on CT. A high specificity
is an important aim for CT myocardial perfusion imaging to
Non obstructive Obstructive Non obstructive Obstructive
Non obstructive Obstructive Non obstructive Obstructive
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Fig. 1 Assessment of myocardial blood flow by 15O-water positron
emission tomography as compared to computed tomography coronary
angiography (CTCA) and myocardial perfusion (CTP) and invasive
coronary angiography (ICA) with fractional flow reserve (FFR).
Baseline and hyperaemic myocardial blood flow in obstructive and
non-obstructive vessels as defined by a, b ICA/FFR and c, d
CTCA/CTP. e, f Correlation between myocardial blood flow corrected
for rate pressure product and CT contrast enhancement at rest and during
hyperaemia respectively
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enable this to be used to guide referrals for invasive coronary
angiography. CT can be used to minimize the number of nor-
mal invasive coronary angiographies performed and also pro-
vide additional information on anatomy in order to plan revas-
cularization. It is hoped that in the future this could also be used
to plan bypass surgery in relevant patients, without the require-
ment for invasive coronary angiography.
In our study, the optimal cut-off to identify hemody-
namically significant stenoses was 0.78 mL/(g/min).
Previous studies have reported optimal cut-off values
between 1.86 and 2.5 mL/(g/min) [11, 13, 14, 32, 33].
However, our study did not include healthy volunteers
and had a high proportion of patients with CAD.
Myocardial blood flow is known to be lower in normal
regions remote from those with an obstructive stenosis
in patients after acute myocardial infarction, as com-
pared to normal controls [25]. Reduced coronary flow
velocity reserve has also been identified in women with
chest pain without obstructive coronary artery disease
on invasive coronary angiography, possibly highlighting
microvascular dysfunction [34].
A variety of doses of 15O-water have been used in
previous studies, including lower doses than used in this
study [35, 36]. Although current guidelines recommend
a 700–1500 MBq 15O-water bolus [37], improved detec-
tor sensitivity in the latest generation scanners means
that lower doses are appropriate, but may lead to vari-
ations in the results. Together, these factors may help
explain the lower thresholds identified in our study. The
higher 15O-water PET myocardial blood flow identified
in normal as compared to non-obstructive coronary ar-
teries suggests the potential impact of microvascular dis-
ease on myocardial blood flow in patients with non-
obstructive coronary artery disease. This difference was
not statistically significant in our study but this does
warrant further investigation.
This study assessed snapshot CTPwhere a small number of
images are acquired just after the peak of contrast enhance-
ment, rather than dynamic CTP that acquires multiple images
during the wash-in and wash-out of contrast. Myocardial
blood flow calculated using dynamic CTP correlates with
15O-water PET myocardial blood flow [38]. However,
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Fig. 2 Baseline (a) and hyperaemic (b) myocardial blood flow assessed by 15O-water positron emission tomography in normal, non-obstructive and
obstructive vessels as defined by computed tomography coronary angiography and myocardial perfusion
Table 3 Optimal cut-off value for hyperaemic myocardial blood flow (MBF) on per-vessel assessment to identify obstructive stenosis as defined by
ICA/FFR or CTCA/CTP
Cut-off value (mL/(g/min)) Area under the curve Sensitivity (%) Specificity (%)
(95 % CI) P value
ICA/FFR Hyperaemic MBF 0.78 0.897 (0.815, 0.979) <0.001 100 92
CFR 1.02 0.880 (0.773, 0.986) <0.001 100 100
CTCA/CTP Hyperaemic MBF 0.78 0.856 (0.761, 0.951) <0.001 100 95
CFR 1.02 0.880 (0.773, 0.986) 0.02 100 94
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dynamic CTP has a higher radiation dose than snapshot CTP.
Our study shows that semi-quantitative assessment of snap-
shot CTP using CT attenuation density also correlates with
15O-water PET myocardial blood flow. Previous studies have
suggested that rest images alone are sufficient to identify ob-
structive CAD [39]. However, our data do not support this as
rest imaging alone was not sufficient to discriminate between
obstructive and non-obstructive lesions.
The use of medications such as glyceryl trinitrate or beta-
blockers prior to CTP could alter the presence or severity of
perfusion defects [40]. However, previous studies have shown
no difference in hyperaemic myocardial blood flow measured
with 13N-ammonia in patients taking beta-blockers [41]. In
addition the diagnostic accuracy of CTCA/CTP identified in
our study was similar to previous studies where medications
such as beta-blockers and nitrates were withheld. There is also
significant heterogeneity in resting myocardial blood flow be-
tween individuals receiving these medications [10, 16, 33].
The number of patients included in this study was small and
the overall prevalence of CAD was relatively high. Selection
bias may also have been introduced as only 19% consented to
participate in this study. This means that assessment of the
additive value of CTP over CTCA was difficult to assess. In
addition FFR assessment was only performed in major epicar-
dial vessels with stenosis greater than 50 % where technically
possible, which may have led to misclassification. Indeed, it is
not always possible in a clinical setting to perform FFR be-
cause of vessel size or tortuosity. This is an inherent limitation
of this Bgold standard^, but nevertheless FFR is widely used
clinically to guide patient management. Despite having high
inter- and intraobserver variability [15] and good agreement
between software packages [35], 15O-water PET analysis has
limitations including potential problems with bolus delivery,
PET resolution, patient motion and suboptimal hyperaemia.
In conclusion, this study assessed CTP in comparison
to 15O-water PET myocardial blood flow and functional
severity of coronary stenosis assessed by fractional flow
reserve. We have shown that CTCA/CTP provides a
robust physiological and clinical assessment of patients
with suspected CAD, with excellent correlation with
myocardial blood flow and comparable diagnostic accu-
racy to current invasive gold standard approaches of
ICA and FFR. This is the first study to assess the
semi-quantitative assessment of CT myocardial perfu-
sion attenuation density as compared to 15O-water
PET. We believe that CTCA combined with CTP can
now be performed in the clinical assessment of patients
with suspected CAD.
Table 4 Myocardial contrast enhancement for obstructive and non-
obstructive segments as defined by ICA and FFR
Non-obstructive Obstructive P
Myocardial contrast enhancement (HU)
Rest 86 (84, 88) 73 (71, 76) <0.001
Stress 111 (107, 114) 101 (96, 106) 0.001
Endocardium contrast enhancement (HU)
Rest 95 (93, 97) 84 (80, 87) <0.001
Stress 115 (111, 118) 102 (98, 107) <0.001
CT contrast corrected for left ventricle enhancement (HU)
Rest 0.17 (0.17, 0.18) 0.15 (0.14, 0.16) <0.001
Stress 0.37 (0.36, 0.39) 0.30 (0.28, 0.32) <0.001
CT corrected for rate pressure product (HU)
Rest 90 (86, 93) 81 (76, 86) 0.004
Stress 124 (114, 134) 118 (108, 127) 0.330
Transmyocardial perfusion ratio
Rest 1.62 (1.54, 1.71) 1.91 (1.69, 2.13) <0.001
Stress 1.23 (1.19, 1.28) 0.98 (0.93, 1.04) <0.001
Mean (95 % confidence interval)
Table 5 Correlation between
oxygen-15 PETmyocardial blood
flow and computed tomography
myocardial perfusion imaging at
rest and during adenosine stress:
for PET parameters as compared
to CT myocardial attenuation
density; and for CT parameters as
compared to oxygen-15 PET
myocardial blood flow corrected
for rate pressure product
Baseline Hyperaemia
PET parameters vs CT myocardial attenuation density
PET total coronary resistance 0.278, <0.001 0.274, <0.001
PET myocardial blood flow −0.227, <0.001 0.230, <0.001
Change in PET myocardial blood flow 0.307, <0.001 0.278, <0.001
PET coronary vasodilator reserve 0.411, <0.001 0.460, <0.001
PET myocardial blood flow corrected for rate pressure product −0.235, <0.001 0.553, <0.001
CT parameter vs oxygen-15 PET myocardial blood flow
CT attenuation density −0.235, <0.001 0.553, <0.001
Endocardium CT attenuation density 0.328, <0.001 0.601, <0.001
CT attenuation density corrected for left ventricular enhancement −0.136, 0.01 0.269, <0.001
CT attenuation density corrected for rate pressure product 0.19, <0.001 0.579, <0.001
Transmyocardial perfusion ratio 0.172, 0.0002 0.214, <0.001
r value, P value
Eur Radiol
Fig. 3 Example images from CT, PET and ICA. This 74-year-old non-
smoker with hypertension, hypercholesterolaemia and atypical chest pain
underwent multimodality assessment of his cardiac anatomy and
physiology. a Short-axis basal, mid and apical images of the left
ventricle at rest and during hyperaemia along with three-dimensional
representations of the transmyocardial perfusion ratio and coronary
anatomy. Hypoattenutation is seen in right coronary artery (RCA) and
left anterior descending (LAD) artery during hyperaemia. There is also
mild hypoattenuation in the RCA territory on rest imaging. b
Corresponding 15O-water PET images which identified the same
perfusion abnormalities in terms of the absolute myocardial blood flow
(mL/(g/min)). c Corresponding images from ICA which identified an
occluded LAD and severe stenosis of the RCAwith FFR less than 0.80
Eur Radiol
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